Home HPTN
Structure
Research
Sites
Community Ethics Prevention
Science
HPTN Studies Network
Information
Site Map

Study Status Table

 

Studies & Sites Table

 

Studies by Country

 

Studies by Research Area

 

Study Phase Definitions


HPTN 039

A Phase III, randomized, double-blind, placebo-controlled trial of acyclovir for the reduction of HIV acquisition among high risk HSV-2 seropositive, HIV-seronegative individuals

039Navigation

039 Quick Links

HPTN 039 Study summary

HPTN 039 Background

HPTN 039 Q&A

HPTN 039 Data Communiqué #4

HPTN 039 Data Communiqué #3

HPTN 039 Data Communiqué #2

HPTN 039 Data Communiqué #1

HPTN 039 SSP Manual 17 September 2004 (PDF)

HPTN 039 v 3.0 Protocol & successive docs (PDF)

Amendment 2 Summary

HPTN 039 v 2.0 Protocol & successive docs (PDF)

Amendment 1 Summary

HPTN 039 v 1.0 Protocol (PDF)

HPTN 039 Meetings & Presentations

HPTN 039-01-Ancillary

HPTN 039 Alias Lists

Meetings and Presentations

HPTN 039 WSM Retreat (May 18-19, 2007)
Download Retreat notebook documents (zip file)

HPTN Annual Meeting 039 Session, February 22, 2006

Africa Team: Zimbabwe-Zambia-South Africa Training & Implementation Summit #2, January 20-22, 2006

Individual Report Sections

 

      

Send any questions or comments regarding this site to: hptn@fhi.org
Please read the HPTN Disclaimer

National Institutes of Health

National Institute of Allergy and Infectious Diseases

This page was last updated: June 07, 2007